Stempoint Capital’s Enliven Therapeutics ELVN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-120,430	Closed	-$2.37M	–	59
2025 Q1	$2.37M	Buy	120,430 +23,714	+25%	+$467K	0.76%	31
2024 Q4	$2.18M	Buy	+96,716	New	+$2.18M	0.54%	40